Aliases: Bufferin, Zorpin
Indications: Chest Pain from suspected Acute Coronary Syndrome/STEMI/ACO
Contraindications: Anaphylaxis, known ulcer & active GI bleeding
Concentrations:
Tablet: 81 mg
Dosing
Adult:
| Indication | Dose | Route | Note |
| Suspected ACS or STEMI | 324mg | PO | may give full amount if already taken earlier in the day |
Pediatric:
| Indication | Dose | Route | Note |
| None |
Precautions:
On blood thinners.
Pregnancy Category D: There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious disease for which safer drugs cannot be used or are ineffective).
Adverse/Side Effects: N/V, diarrhea, heartburn, GI bleeding
Class: Analgesic, Antipyretic, NSAID, platelet inhibitor
Mechanism of Action: Inhibits the formation of prostaglandins associated with pain, fever, and inflammation. Inhibits platelet aggregation by acetylating cyclooxygenase permanently disabling it so that it cannot synthesize prostaglandins and Thromboxanes. Since Thromboxane A2 is important in clotting its absence does not allow blood to clot effectively.
| Onset of Action | Peak Effect | Duration of Action |
| < 1 hour | 1-2 hours | 4-6 hours |